health canada approval zepbound tirzepatide obesity canada date F.D.A. Approves New Drug That Will Compete With Wegovy Health Canada approves weight-loss drug

One emerging strategy in diabetes management is the use of retatrutide, a novel medication that has shown promise in effectively controlling blood sugar levels

Wang AF, Zou XJ, Wu JJ, Ma QY, Yuan NJ, Ding FM, et al

It may also cause birth defects if taken during pregnancy, and may cause depression, leading the FDA to limit its use for the most severe cases of cystic acne

, ,

Talk to a Provider About GLP-1 Treatment Digestive symptoms such as diarrhea are among the most commonly reported side effects of medications like Ozempic

Key findings: Those Who Stayed on the Maximum Tolerated Dose After 60 weeks of weight loss on tirzepatide, people who stayed on the same dose during a maintenance stage (52 weeks) kept off all the weight (about 50 pounds)